Covid-19 created the perfect storm for the pharma industry’s already challenged supply chain network. The pandemic augmented supply chain risk and exposed weak areas such as the lack of end-to-end visibility. That’s an observation from Daniel Carchedi, Senior Director of Business Development and Strategy, Microsoft Health and Life Sciences.
Carchedi led a panel discussion, “Digital ecosystems and how to future proof supply chains,” on how tech companies, such as Microsoft and Accenture, are closely collaborating with the pharma industry as they seek to repair and improve manufacturing supply chain issues exposed by the Covid-19 pandemic.
Read more...
About the Author
EcoVadis is a purpose-driven company whose mission is to provide the world's most trusted business sustainability ratings. Businesses of all sizes rely on EcoVadis’ expert intelligence and evidence-based ratings to manage risk and compliance, drive decarbonization, and improve the sustainability performance of their business and value chain. Its AI-powered risk mapping, actionable scorecards, benchmarks, carbon action tools, and insights guide a resilience and improvement journey for environmental, social and ethical practices across 200 industry categories and 175 countries.
Follow on Linkedin
Visit Website
More Content by EcoVadis EN